Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-11-03

Clinical Trial Update: A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive Disorder (MDD) [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated the combination of Elzasonan with sertraline (Zoloft) versus sertraline alone or placebo in adults with major depressive disorder; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Elzasonan
  • Zoloft (sertraline)

Snippet

Sponsor: Pfizer | Conditions: Depressive Disorder, Major | Phase 2 | Status: COMPLETED